Earnings Reportpositive

Earnings Report

Other upcoming events for ADCT

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemothera

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — ADCT Earnings Report | BioSniper